We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
We kick off another week of trading with the Dow Jones having posted nine straight up days — a new record. Positive Q2 earnings results overall (and Apple [(AAPL - Free Report) ] in specific) and better-than-expected economic data such as last Friday’s non-farm payroll numbers (complete with an historically low 4.3% Unemployment rate) have helped moved the index of 30 blue chips to all-time highs. Can this continue?
We’re not looking at quite as busy a week for econ data, or even high-profile earnings reports — although Thursday begins to final leg of earnings season, which brings the slew of publicly traded retailers to the fore with Macy’s (M) results before the bell that day. Otherwise, aside from a couple Fed presidents signaling the direction of FOMC policy ahead of its session coming up in September, and a CPI headline late this week, we begin to enter the seasonally dormant period on the trading calendar.
This morning, Tyson Foods (TSN - Free Report) beat earnings estimates by a penny at $1.28 per share on revenues of $9.85 billion, which also topped expectations of $9.48 billion. These represent growth of 6% and 4.8% year over year, respectively. Also, Tyson raised full-year earnings guidance to a range of $4.95-5.05, 13% growth year over year.
Anti-inflammatory treatment specialist Horizon Pharma is climbing 14% in today’s pre-market after far surpassing the Zacks consensus of 12 cents per share in its earnings reports — 26 cents per share (accounting for stock-based compensation expenses) more than doubled expectations. Revenues of $289.5 million easily topped the $235 million anticipated. Chronic gout treatment Krystexxa grew 93% year over year, and the company upped its full-year sales guidance to over $1 billion per year.
After today’s closing bell, Marriott International (MAR - Free Report) will report quarterly earnings, which follows this morning’s news that the global hotelier is teaming up with Alibaba (BABA - Free Report) , whereby users of the Internet giant will be able to book hotel rooms at Marriott directly. This has led to a more than 3% jump in Marriott shares in today’s pre-market. The company is one of the very many these days trading at all-time highs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Dow To Continue Rally?
We kick off another week of trading with the Dow Jones having posted nine straight up days — a new record. Positive Q2 earnings results overall (and Apple [(AAPL - Free Report) ] in specific) and better-than-expected economic data such as last Friday’s non-farm payroll numbers (complete with an historically low 4.3% Unemployment rate) have helped moved the index of 30 blue chips to all-time highs. Can this continue?
We’re not looking at quite as busy a week for econ data, or even high-profile earnings reports — although Thursday begins to final leg of earnings season, which brings the slew of publicly traded retailers to the fore with Macy’s (M) results before the bell that day. Otherwise, aside from a couple Fed presidents signaling the direction of FOMC policy ahead of its session coming up in September, and a CPI headline late this week, we begin to enter the seasonally dormant period on the trading calendar.
This morning, Tyson Foods (TSN - Free Report) beat earnings estimates by a penny at $1.28 per share on revenues of $9.85 billion, which also topped expectations of $9.48 billion. These represent growth of 6% and 4.8% year over year, respectively. Also, Tyson raised full-year earnings guidance to a range of $4.95-5.05, 13% growth year over year.
Anti-inflammatory treatment specialist Horizon Pharma is climbing 14% in today’s pre-market after far surpassing the Zacks consensus of 12 cents per share in its earnings reports — 26 cents per share (accounting for stock-based compensation expenses) more than doubled expectations. Revenues of $289.5 million easily topped the $235 million anticipated. Chronic gout treatment Krystexxa grew 93% year over year, and the company upped its full-year sales guidance to over $1 billion per year.
After today’s closing bell, Marriott International (MAR - Free Report) will report quarterly earnings, which follows this morning’s news that the global hotelier is teaming up with Alibaba (BABA - Free Report) , whereby users of the Internet giant will be able to book hotel rooms at Marriott directly. This has led to a more than 3% jump in Marriott shares in today’s pre-market. The company is one of the very many these days trading at all-time highs.